Your browser doesn't support javascript.
loading
Functionalized mesoporous silica nanoparticles in anticancer therapeutics.
Barkat, Abul; Beg, Sarwar; Panda, Sunil K; S Alharbi, Khalid; Rahman, Mahfoozur; Ahmed, Farhan J.
  • Barkat A; Department of Pharmaceutics, School of Medical & Allied Sciences, KR Mangalam University, Gurgaon, Sohna, Haryana, India.
  • Beg S; Department of Pharmaceutics, School of Pharmaceutical Education & Research, Jamia Hamdard (Hamdard University), New Delhi, India. Electronic address: sarwar.beg@jamiahamdard.ac.in.
  • Panda SK; Research Director, Menovo Pharmaceuticals Research Lab, Ningbo, People's Republic of China.
  • S Alharbi K; Department of Pharmacology, College of Pharmacy, Jouf University, Sakakah, Kingdom of Saudi Arabia.
  • Rahman M; Department of Pharmaceutical Sciences, SIHAS, Sam Higginbottom University of Agriculture, Technology & Sciences, Allahabad, UP, India. Electronic address: mahfoozur.rahman@shiats.edu.in.
  • Ahmed FJ; Department of Pharmaceutics, School of Pharmaceutical Education & Research, Jamia Hamdard (Hamdard University), New Delhi, India. Electronic address: fjahmad@jamiahamdard.ac.in.
Semin Cancer Biol ; 69: 365-375, 2021 02.
Article en En | MEDLINE | ID: mdl-31442571
ABSTRACT
The application of nanomedicines in tumor targeting and attaining meaningful therapeutic benefits for the treatment of cancers has been going on for almost two decades. Beyond the lipidic and polymeric nanomedicines-based passive and active targeting, the quest for inventing the new generation of carriers has no end. This has lead to the evolution of some of the unique carrier systems with supramolecular assembly structures. Mesoporous nanoparticulate systems (MSNPs) are the recently explored substances with favorable potential for drug delivery and drug targeting applications especially in cancer chemotherapeutics. Notwithstanding their physical properties that makes them a suitable carrier for cancer treatment, but their outstanding ability towards chemical functionalization helps in delivering the imaging agents for diagnostic applications. MSNPs can improve the dissolution rate and systemic availability of the poorly water soluble drugs due to their mesoporous structures. Besides, guest molecules including targeting ligands, biomimetic agents, fluorescent dyes, and biocompatible polymers can be efficiently encapsulated in their tunable porous structure for targeting purpose. Some special features of the MSNPs which make them one of the highly effective nanocarrier systems include their ability to encapsulate non-crystalline drugs in their mesopores, high dispersion ability as a function of large surface area and wetting properties. For anticancer drug delivery, MSNPs are worthful to provide excellent drug loading capacity and endocytotic behavior. Moreover, the external surface of MSNPs can be precisely modified for tumor-recognition and developing sensitivity of the antitumor agents towards the cancer cells. Owing to the innumerable applications of MSNPs till now in cancer treatment, the present article particularly focuses to provide an overview account with complete details on the topic to make the readers abreast with details on physiochemical and material properties of MSNPs, their applications and current innovations for the purpose.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sistemas de Liberación de Medicamentos / Dióxido de Silicio / Nanomedicina / Nanopartículas / Neoplasias / Antineoplásicos Límite: Animals / Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sistemas de Liberación de Medicamentos / Dióxido de Silicio / Nanomedicina / Nanopartículas / Neoplasias / Antineoplásicos Límite: Animals / Humans Idioma: En Año: 2021 Tipo del documento: Article